UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course

The European respiratory journal, 2017-03, Vol.49 (3), p.1600537-1600537

2017

Volltextzugriff (PDF)

Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.2972-2977

2015

Volltextzugriff (PDF)

Performance Assessment of Xpert MTB/RIF Assay for Detecting Pulmonary Tuberculosis and Rifampin Resistance in a Tertiary Care Hospital in Korea

Japanese Journal of Infectious Diseases, 2021/11/22, Vol.74(6), pp.537-542

2021

Volltextzugriff (PDF)

Safety of latent tuberculosis infection treatment in older patients with immune-mediated inflammatory diseases

Clinical rheumatology, 2022-03, Vol.41 (3), p.889-897

2022

Volltextzugriff (PDF)

Drug‐level change and optimal dose adjustment of tacrolimus with the use of rifabutin for treating mycobacterial disease in solid organ transplant recipients

Transplant infectious disease, 2022-08, Vol.24 (4), p.e13893-n/a

2022

Volltextzugriff (PDF)

Spontaneous sputum conversion and reversion in Mycobacterium abscessus complex lung disease

PloS one, 2020-04, Vol.15 (4), p.e0232161-e0232161

2020

Volltextzugriff (PDF)

Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection

PloS one, 2020-06, Vol.15 (6), p.e0234700-e0234700

2020

Volltextzugriff (PDF)

Incidence, risk factors, and clinical characteristics of airway complications after lung transplantation

Scientific reports, 2023-01, Vol.13 (1), p.667-667, Article 667

2023

Volltextzugriff (PDF)

Diagnostic yield of post-bronchoscopy sputum for diagnosing pauci-bacillary pulmonary tuberculosis

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.576-580

2021

Volltextzugriff (PDF)

Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease

Respiratory medicine, 2021-04, Vol.179, p.106340-106340, Article 106340

2021

Volltextzugriff (PDF)

Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease

Respiratory medicine, 2017-12, Vol.133, p.36-41

2017

Volltextzugriff (PDF)

Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid

International journal of infectious diseases, 2020-09, Vol.98, p.478-485

2020

Volltextzugriff (PDF)

Successful Treatment with a High-dose Rifampin-containing Regimen for Pulmonary Tuberculosis with a Disputed rpoB Mutation

Internal Medicine, 2018/11/15, Vol.57(22), pp.3281-3284

2018

Volltextzugriff (PDF)

Evaluation of a lateral flow assay–based IFN-γ release assay as a point-of-care test for the diagnosis of latent tuberculosis infection

Clinical rheumatology, 2021-09, Vol.40 (9), p.3773-3781

2021

Volltextzugriff (PDF)

Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis

Respiratory medicine, 2017-10, Vol.131, p.43-48

2017

Volltextzugriff (PDF)

A Clofazimine-Containing Regimen Confers Improved Treatment Outcomes in Macrophages and in a Murine Model of Chronic Progressive Pulmonary Infection Caused by the Mycobacterium avium Complex

Frontiers in microbiology, 2021-01, Vol.11, p.626216-626216

2021

Volltextzugriff (PDF)

Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities

PloS one, 2017-03, Vol.12 (3), p.e0174240-e0174240

2017

Volltextzugriff (PDF)

The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease

Respiratory medicine, 2019-04, Vol.150, p.45-50

2019

Volltextzugriff (PDF)

Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-08, Vol.28 (8), p.1098-1104

2022

Volltextzugriff (PDF)

Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021-08, Vol.27 (8), p.1156-1161

2021

Volltextzugriff (PDF)

Association Between Duration of Aminoglycoside Treatment and Outcome of Cavitary Mycobacterium avium Complex Lung Disease

Clinical infectious diseases, 2019-05, Vol.68 (11), p.1870-1876

2019

Volltextzugriff (PDF)

Treatment outcomes of the interstitial lung disease subtype of unclassifiable type Mycobacterium avium complex pulmonary disease

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-08, Vol.28 (8), p.1112-1118

2022

Volltextzugriff (PDF)

Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA

PloS one, 2018-07, Vol.13 (7), p.e0198756-e0198756

2018

Volltextzugriff (PDF)

Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients

Transplant international, 2016-05, Vol.29 (5), p.549-558

2016

Volltextzugriff (PDF)

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(160)

Publikationsform

Sprache

Englisch
(155)
Japanisch
(14)
Koreanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course

Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease

9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea

Performance Assessment of Xpert MTB/RIF Assay for Detecting Pulmonary Tuberculosis and Rifampin Resistance in a Tertiary Care Hospital in Korea

Safety of latent tuberculosis infection treatment in older patients with immune-mediated inflammatory diseases

Drug‐level change and optimal dose adjustment of tacrolimus with the use of rifabutin for treating mycobacterial disease in solid organ transplant recipients

Spontaneous sputum conversion and reversion in Mycobacterium abscessus complex lung disease

Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection

Incidence, risk factors, and clinical characteristics of airway complications after lung transplantation

Diagnostic yield of post-bronchoscopy sputum for diagnosing pauci-bacillary pulmonary tuberculosis

Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease

Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease

Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid

Successful Treatment with a High-dose Rifampin-containing Regimen for Pulmonary Tuberculosis with a Disputed rpoB Mutation

Evaluation of a lateral flow assay–based IFN-γ release assay as a point-of-care test for the diagnosis of latent tuberculosis infection

Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis

A Clofazimine-Containing Regimen Confers Improved Treatment Outcomes in Macrophages and in a Murine Model of Chronic Progressive Pulmonary Infection Caused by the Mycobacterium avium Complex

Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities

The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease

Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation

Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease

Association Between Duration of Aminoglycoside Treatment and Outcome of Cavitary Mycobacterium avium Complex Lung Disease

Treatment outcomes of the interstitial lung disease subtype of unclassifiable type Mycobacterium avium complex pulmonary disease

Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA

Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients

Suchergebnisse filtern